CD226 and myeloid sarcoma: In untreated NMOSD patients, in contrast to untreated-MS patients, we found a positive correlation between four CD4+/CD8+ICOS+CD226+ T cell sub-clusters (T1, T4, T6 and T15) and S-I-specific CD4+ T cell activity (Fig. 5J).